Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial
Related Posts
Patel A, Kuo A. The Ethics of Gene Therapy for Sickle Cell Disease. Cureus. 2025 Mar 23;17(3):e81037. doi: 10.7759/cureus.81037. PMID: 40264617; PMCID: PMC12013961.
Bachour K, Shah S, Reichl A, Chia J, Shabsovich DS, Castillo A, Cho G. Surviving the Odds: Primary Cardiac Lymphoma With Locoregional Lymph Node Involvement[...]
Joseph Davey D, de Voux A, Shaetonhodi N, Marks M, Frigati L, Kufa T. Opportunities to Optimize Outcomes of Diagnosis and Treatment of HIV and[...]